Comparison of the Effectiveness of Percutaneous Intervention of the Left-Main Coronary Artery With Everolimus-Eluting Stents in Women -Vs- Men

American Journal of Cardiology

13 September Sep 2019 9 days ago
  • Trabattoni D, Teruzzi G, Montorsi P, Fabbiocchi F, Gili S, Calligaris G, Grancini L, Galli S, Ravagnani P, Bartorelli A

Everolimus-eluting stents are largely used for left main (LM) percutaneous coronary interventions (PCI). Long-term follow-up of patients who underwent LM PCI in a real world clinical setting, in particular women, have been scarcely reported. Consecutive patients who underwent unprotected LM PCI with EES at a single Institution from December 2006 to April 2016 were included. Main outcome assessed was the occurrence of major adverse cardiovascular events (MACE) as a composite of death, myocardial infarction or target lesion revascularization at follow-up.

Reference

Trabattoni D, Teruzzi G, Montorsi P, Fabbiocchi F, Gili S, Calligaris G, Grancini L, Galli S, Ravagnani P, Bartorelli A. Comparison of the Effectiveness of Percutaneous Intervention of the Left-Main Coronary Artery With Everolimus-Eluting Stents in Women -Vs- Men. Am J Cardiol 2019 Aug 16. pii: S0002-9149(19)30891-4. doi: 10.1016/j.amjcard.2019.07.060

Go to PubMed